Long-term impact of anthracycline in early-stage breast cancer, bridging of MiRNAs profiler for early cardiotoxicity

Abstract Background Anthracyclines are essential in early breast cancer chemotherapy but pose long-term cardiotoxicity risks. Objectives This study aims to investigate the long-term incidence of cancer therapy-related cardiac dysfunction (CTRCD), bridging with the miRNAs profiler representing acute...

Descrición completa

Detalles Bibliográficos

Principais autores:	Nattaya Poovorawan, Thiti Susiriwatananont, Chinachote Teerapakpinyo, Pajaree Chariyavilaskul, Piyada Sitthideatphaiboon, Luxica Jarutasnangkul, Monravee Tumkosit, Pairoj Chattranukulchai, Nonthikorn Theerasuwipakorn, Chatchawit Aporntewan, Shanop Shuangshoti, Sopark Manasnayakorn, Chanida Vinayanuwattikun, Yongkasem Vorasettakarnkij, Virote Sriuranpong
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2025-04-01
Series:	Cardio-Oncology
Assuntos:	Cancer therapy-related cardiac dysfunction Long-term cardiotoxicity Cardiac MRI MicroRNAs
Acceso en liña:	https://doi.org/10.1186/s40959-025-00337-2
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!